Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
Condition(s):Oral LeukoplakiaLast Updated:February 13, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Oral LeukoplakiaLast Updated:February 13, 2013Completed
Condition(s):Oral LeukoplakiaLast Updated:October 9, 2014Terminated
Condition(s):Head and Neck CancerLast Updated:April 12, 2013Completed
Condition(s):Leukoplakia, Hairy; HIV InfectionsLast Updated:June 24, 2005Completed
Condition(s):Leukoplakia, OralLast Updated:March 7, 2024Recruiting
Condition(s):Oral Leukoplakia; Oral Leukoplakia of Tongue; Oral Leukoplakia of Gingiva; Oral Lichen PlanusLast Updated:December 3, 2019Recruiting
Condition(s):Head and Neck Cancer; Oral LeukoplakiaLast Updated:February 11, 2022Completed
Condition(s):Leukoplakia; Periodontal DiseaseLast Updated:March 4, 2008Completed
Condition(s):Vulvar Lichen SclerosusLast Updated:February 5, 2024Recruiting
Condition(s):Lip and Oral Cavity Cancer; Oral Leukoplakia; Oropharyngeal Cancer; Tongue CancerLast Updated:December 19, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.